Stifel Financial Corp Revance Therapeutics, Inc. Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.34 - $4.73 $1,949 - $3,940	-833 Reduced 1.24%	66,325 $170,000
Q1 2024 May 13, 2024	BUY	$4.65 - $9.31 $224,181 - $448,844	48,211 Added 254.45%	67,158 $330,000
Q4 2023 Feb 12, 2024	BUY	$5.81 - $11.2 $23,187 - $44,699	3,991 Added 26.68%	18,947 $166,000
Q3 2023 Nov 13, 2023	BUY	$11.47 - $25.07 $8,029 - $17,549	700 Added 4.91%	14,956 $171,000
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $16,302 - $24,822	-660 Reduced 4.42%	14,256 $360,000
Q1 2023 May 12, 2023	SELL	$18.36 - $35.27 $37,380 - $71,809	-2,036 Reduced 12.01%	14,916 $480,000
Q4 2022 Feb 13, 2023	SELL	$18.32 - $30.66 $87,020 - $145,635	-4,750 Reduced 21.89%	16,952 $312,000
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $70,804 - $140,670	4,941 Added 29.48%	21,702 $586,000
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $193,086 - $341,924	16,761 New	16,761 $232,000
Q4 2021 Feb 14, 2022	SELL	$12.46 - $27.87 $197,453 - $441,655	-15,847 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.78 - $33.21 $94,535 - $121,781	3,667 Added 30.11%	15,847 $442,000
Q2 2021 Aug 13, 2021	BUY	$26.8 - $31.84 $2,251 - $2,674	84 Added 0.69%	12,180 $362,000
Q1 2021 May 14, 2021	SELL	$24.03 - $29.97 $42,797 - $53,376	-1,781 Reduced 12.83%	12,096 $338,000
Q4 2020 Feb 12, 2021	BUY	$23.41 - $28.34 $67,561 - $81,789	2,886 Added 26.26%	13,877 $393,000
Q3 2020 Nov 16, 2020	SELL	$23.23 - $34.3 $63,441 - $93,673	-2,731 Reduced 19.9%	10,991 $276,000
Q2 2020 Aug 14, 2020	BUY	$12.6 - $26.55 $1,285 - $2,708	102 Added 0.75%	13,722 $335,000
Q1 2020 May 14, 2020	SELL	$12.46 - $27.81 $72,778 - $162,438	-5,841 Reduced 30.01%	13,620 $204,000
Q4 2019 Feb 13, 2020	SELL	$11.66 - $20.15 $50,091 - $86,564	-4,296 Reduced 18.08%	19,461 $319,000
Q3 2019 Nov 19, 2019	BUY	$10.22 - $14.5 $7,685 - $10,904	752 Added 3.27%	23,757 $312,000
Q3 2019 Nov 13, 2019	BUY	$10.22 - $14.5 $12,274 - $17,414	1,201 Added 5.51%	23,005 $302,000
Q2 2019 Aug 14, 2019	SELL	$10.67 - $15.49 $65,268 - $94,752	-6,117 Reduced 21.91%	21,804 $286,000
Q1 2019 May 14, 2019	BUY	$15.4 - $20.39 $429,983 - $569,309	27,921 New	27,921 $438,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account